Cargando…

Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey

Background: Soon after the COVID-19 pandemic was declared, a pharmaceutical company expressed rapid interest in developing a safe and effective vaccine candidate to contain the spread of SARS-CoV-2 infections. The FDA approved the Pfizer-BioNTech, AstraZeneca, Moderna, and Janssen vaccines. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqurashi, Afnan, Sindy, Enas A., Dosh, Heba, Khayat, Sumaya Z., Alqarna, Lujain M., Sodagar, Wafa M., Samannodi, Mohammed, Alwafi, Hassan, Salawati, Emad, Almatrafi, Mohammed A., Ekram, Rakan, Bagadood, Rehab M., Alsafi, Radi, Assaggaf, Hamza M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657038/
https://www.ncbi.nlm.nih.gov/pubmed/36360769
http://dx.doi.org/10.3390/ijerph192113889
_version_ 1784829590344040448
author Alqurashi, Afnan
Sindy, Enas A.
Dosh, Heba
Khayat, Sumaya Z.
Alqarna, Lujain M.
Sodagar, Wafa M.
Samannodi, Mohammed
Alwafi, Hassan
Salawati, Emad
Almatrafi, Mohammed A.
Ekram, Rakan
Bagadood, Rehab M.
Alsafi, Radi
Assaggaf, Hamza M.
author_facet Alqurashi, Afnan
Sindy, Enas A.
Dosh, Heba
Khayat, Sumaya Z.
Alqarna, Lujain M.
Sodagar, Wafa M.
Samannodi, Mohammed
Alwafi, Hassan
Salawati, Emad
Almatrafi, Mohammed A.
Ekram, Rakan
Bagadood, Rehab M.
Alsafi, Radi
Assaggaf, Hamza M.
author_sort Alqurashi, Afnan
collection PubMed
description Background: Soon after the COVID-19 pandemic was declared, a pharmaceutical company expressed rapid interest in developing a safe and effective vaccine candidate to contain the spread of SARS-CoV-2 infections. The FDA approved the Pfizer-BioNTech, AstraZeneca, Moderna, and Janssen vaccines. Here, we investigated the attitude and acceptance of using different generic types of COVID-19 vaccines in Saudi Arabia. Methods: This study is a cross-sectional study using an online survey conducted in Saudi Arabia from the 19th of October to the 6th of December 2021. The questionnaire was distributed using social media platforms such as Twitter, WhatsApp, and Facebook. The inclusion criteria to participate in this study were adults who live in Saudi Arabia (Saudis or non-Saudis) and had two doses of COVID-19 vaccinations. Result: 3486 participants were included in this study, and 67.5% of the participants had side effects after the first dose. Similarly, 66.7% of the study participants had side effects after administering the second dose. Our data showed that most participants were unsure if the heterologous COVID-19 vaccination could cause severe side effects. In addition, 47.6% of the participants refused to receive a different generic type of COVID-19 vaccine due to fear of health problems. However, most participants obtained information regarding COVID-19 vaccination from the Saudi Ministry of Health. Conclusions: We found a low level of acceptance for receiving different generic types of vaccines if the participants had a choice. Therefore, plans should focus on increasing the acceptance level among the Saudi population through official platforms such as the Saudi Ministry of Health and private clinics.
format Online
Article
Text
id pubmed-9657038
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96570382022-11-15 Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey Alqurashi, Afnan Sindy, Enas A. Dosh, Heba Khayat, Sumaya Z. Alqarna, Lujain M. Sodagar, Wafa M. Samannodi, Mohammed Alwafi, Hassan Salawati, Emad Almatrafi, Mohammed A. Ekram, Rakan Bagadood, Rehab M. Alsafi, Radi Assaggaf, Hamza M. Int J Environ Res Public Health Article Background: Soon after the COVID-19 pandemic was declared, a pharmaceutical company expressed rapid interest in developing a safe and effective vaccine candidate to contain the spread of SARS-CoV-2 infections. The FDA approved the Pfizer-BioNTech, AstraZeneca, Moderna, and Janssen vaccines. Here, we investigated the attitude and acceptance of using different generic types of COVID-19 vaccines in Saudi Arabia. Methods: This study is a cross-sectional study using an online survey conducted in Saudi Arabia from the 19th of October to the 6th of December 2021. The questionnaire was distributed using social media platforms such as Twitter, WhatsApp, and Facebook. The inclusion criteria to participate in this study were adults who live in Saudi Arabia (Saudis or non-Saudis) and had two doses of COVID-19 vaccinations. Result: 3486 participants were included in this study, and 67.5% of the participants had side effects after the first dose. Similarly, 66.7% of the study participants had side effects after administering the second dose. Our data showed that most participants were unsure if the heterologous COVID-19 vaccination could cause severe side effects. In addition, 47.6% of the participants refused to receive a different generic type of COVID-19 vaccine due to fear of health problems. However, most participants obtained information regarding COVID-19 vaccination from the Saudi Ministry of Health. Conclusions: We found a low level of acceptance for receiving different generic types of vaccines if the participants had a choice. Therefore, plans should focus on increasing the acceptance level among the Saudi population through official platforms such as the Saudi Ministry of Health and private clinics. MDPI 2022-10-26 /pmc/articles/PMC9657038/ /pubmed/36360769 http://dx.doi.org/10.3390/ijerph192113889 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alqurashi, Afnan
Sindy, Enas A.
Dosh, Heba
Khayat, Sumaya Z.
Alqarna, Lujain M.
Sodagar, Wafa M.
Samannodi, Mohammed
Alwafi, Hassan
Salawati, Emad
Almatrafi, Mohammed A.
Ekram, Rakan
Bagadood, Rehab M.
Alsafi, Radi
Assaggaf, Hamza M.
Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title_full Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title_fullStr Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title_full_unstemmed Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title_short Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the “Mix-and-Match” Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey
title_sort perception and acceptance of using different generic types of covid-19 vaccine, the “mix-and-match” strategy, in saudi arabia: cross-sectional web-based survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657038/
https://www.ncbi.nlm.nih.gov/pubmed/36360769
http://dx.doi.org/10.3390/ijerph192113889
work_keys_str_mv AT alqurashiafnan perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT sindyenasa perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT doshheba perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT khayatsumayaz perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT alqarnalujainm perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT sodagarwafam perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT samannodimohammed perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT alwafihassan perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT salawatiemad perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT almatrafimohammeda perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT ekramrakan perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT bagadoodrehabm perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT alsafiradi perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey
AT assaggafhamzam perceptionandacceptanceofusingdifferentgenerictypesofcovid19vaccinethemixandmatchstrategyinsaudiarabiacrosssectionalwebbasedsurvey